Pfizer Inc agreed to extend its COVID-19 vaccine contract from 2023 to 2026 with the European Union, the Financial Times reported on Tuesday, citing people with knowledge of the matter. The drugmaker has offered to cut the number of doses being supplied by 40 per cent and delay delivery of the shots, ...